Invicro is a global research partner to the pharmaceutical, biotech, and contract research organizations, specializing in enhancing the discovery and development of life-changing drugs. They offer a unique platform that combines expertise, imaging biomarkers, core lab services, analytics, and software to address drug development problems. Invicro's comprehensive solutions include quantitative biomarkers, advanced analytics, and imaging capabilities across various therapeutic areas such as oncology, central nervous system, and respiratory.

Their platform encompasses the Design, Capture, Analysis, and Management of data, ensuring high-quality and tailored studies. With the largest team of PhDs and MDs in the industry, Invicro's experts utilize state-of-the-art technology to customize studies based on specific questions. They also provide a broad range of modalities to deliver consistent and quantifiable data.

Invicro's world-class analytics team, aided by advanced software, delivers deeper understanding and insight through domain knowledge and machine learning. The integration of their management software provides an unsurpassed collaborative experience in end-to-end data management. Overall, Invicro's mission is to visualize and quantify biological and pathological processes to better diagnose, treat, and cure diseases through advanced imaging applications, informatics, and operations that support drug research and development